Precision BioSciences, Inc.DTILNASDAQ
Loading
Year-over-year research & development expense growth
3Y CAGR
+6.3%/yr
Quarterly compound
Percentile
P65
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.89% |
| Q3 2025 | 4.86% |
| Q2 2025 | -8.46% |
| Q1 2025 | -14.58% |
| Q4 2024 | 21.58% |
| Q3 2024 | -24.04% |
| Q2 2024 | 29.09% |
| Q1 2024 | -0.34% |
| Q4 2023 | -9.81% |
| Q3 2023 | 22.73% |
| Q2 2023 | 21.13% |
| Q1 2023 | -14.56% |
| Q4 2022 | 9.06% |
| Q3 2022 | -49.69% |
| Q2 2022 | 16.29% |
| Q1 2022 | -30.79% |
| Q4 2021 | 2.04% |
| Q3 2021 | -30.33% |
| Q2 2021 | 45.49% |
| Q1 2021 | 10.67% |
| Q4 2020 | -7.02% |
| Q3 2020 | -1.23% |
| Q2 2020 | 1.22% |
| Q1 2020 | 24.99% |
| Q4 2019 | 0.57% |
| Q3 2019 | -13.04% |
| Q2 2019 | 14.02% |
| Q1 2019 | 21.72% |
| Q4 2018 | 68.42% |
| Q3 2018 | -10.41% |
| Q2 2018 | 33.90% |
| Q1 2018 | 0.00% |